RBC Capital lowered the firm’s price target on Bright Health to $7 from $16 and keeps a Sector Perform rating on the shares. Liquidity remains the greatest concern as a result of outstanding risk adjustment obligations, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BHG:
